Sun Yanlai, Xu Huirong, Li Zengjun, Han Jianjun, Song Wentao, Wang Junwei, Xu Zhongfa
Department of Colorectal Cancer Surgery, Shandong Cancer Hospital and Institute, 440 Jiyan Road, Jinan, 250117, China.
World J Surg Oncol. 2016 Mar 1;14:61. doi: 10.1186/s12957-016-0816-6.
The objective of this meta-analysis was to compare the clinical and oncologic outcomes of robotic low anterior resection (R-LAR) with conventional laparoscopic low anterior resection (L-LAR).
A search in the MEDLINE, Embase, and Ovid databases was performed for studies published before July 2014 that compared the clinical and oncologic outcomes of R-LAR and L-LAR. The methodological quality of the selected studies was assessed. Depending on statistical heterogeneity, a fixed or random effects model was used for the meta-analysis. The clinical and oncologic outcomes evaluated included operative time, estimated blood loss, length of hospital stay, rate of conversion to open surgery, post-operative complications, circumferential margin status, and number of lymph nodes collected.
Eight studies, including 324 R-LAR cases and 268 conventional L-LAR cases, were analyzed. The meta-analysis showed that R-LAR was associated with a shorter hospital stay (mean difference (MD) = -1.03; 95% confidence interval (CI) = -1.78, -0.28; P = 0.007), lower conversion rate (odds ratio (OR) = 0.08; 95% CI = 0.02, 0.31; P = 0.0002), lower rate of circumferential margin involvement (OR = 0.5; 95% CI = 0.25, 1.01; P = 0.05), and lower overall complication rate (MD = 0.65; 95% CI = 0.43, 0.99; P = 0.04) compared with L-LAR. There was no difference in operative time (MD = 28.4; 95% CI = -3.48, 60.27; P = 0.08), the number of lymph nodes removed (MD = -0.63; 95% CI = -0.78, 2.05; P = 0.38), and days to return of bowel function (MD = -0.15; 95% CI = -0.37, 0.06; P = 0.17).
R-LAR was shown to be associated with a shorter hospital stay, lower conversion rate, lower rate of circumferential margin involvement, and lower overall complication rate compared with L-LAR. There were no differences in operative time, the number of lymph nodes removed, and days to return of bowel function.
本荟萃分析的目的是比较机器人辅助低位前切除术(R-LAR)与传统腹腔镜低位前切除术(L-LAR)的临床和肿瘤学结局。
检索MEDLINE、Embase和Ovid数据库,查找2014年7月之前发表的比较R-LAR和L-LAR临床和肿瘤学结局的研究。评估所选研究的方法学质量。根据统计异质性,采用固定效应或随机效应模型进行荟萃分析。评估的临床和肿瘤学结局包括手术时间、估计失血量、住院时间、转为开放手术的比率、术后并发症、环周切缘状态以及收集的淋巴结数量。
分析了8项研究,包括324例R-LAR病例和268例传统L-LAR病例。荟萃分析表明,与L-LAR相比,R-LAR与住院时间缩短(平均差(MD)=-1.03;95%置信区间(CI)=-1.78,-0.28;P=0.007)、转化率较低(比值比(OR)=0.08;95%CI=0.02,0.31;P=0.0002)、环周切缘受累率较低(OR=0.5;95%CI=0.25,1.01;P=0.05)以及总体并发症发生率较低(MD=0.65;95%CI=0.43,0.99;P=0.04)相关。手术时间(MD=28.4;95%CI=-3.48,60.27;P=0.08)、切除的淋巴结数量(MD=-0.63;95%CI=-0.78,2.05;P=0.38)和肠功能恢复天数(MD=-0.15;95%CI=-0.37,0.06;P=0.17)无差异。
与L-LAR相比,R-LAR与住院时间缩短、转化率较低、环周切缘受累率较低以及总体并发症发生率较低相关。手术时间、切除的淋巴结数量和肠功能恢复天数无差异。